相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice
James Francescangeli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)
Michel Panisset et al.
PHARMACOTHERAPY (2014)
Switch from selegiline to rasagiline is beneficial in patients with Parkinson's disease
Thomas Mueller et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
The Effect of Safinamide, a Novel Drug for Parkinson's Disease, on Pressor Response to Oral Tyramine: A Randomized, Double-Blind, Clinical Trial
A. Marquet et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients
Fabrizio Stocchi et al.
MOVEMENT DISORDERS (2012)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A systematic review of prevalence studies of depression in Parkinson's disease
Jennifer S. A. M. Reijnders et al.
MOVEMENT DISORDERS (2008)
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness
MBH Youdim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Symptom relief in Parkinson disease by safinamide - Biochemical and clinical evidence of efficacy beyond MAO-B inhibition
F. Stocchi et al.
NEUROLOGY (2006)
A reliable index for the prognostic significance of blood pressure variability
L Mena et al.
JOURNAL OF HYPERTENSION (2005)
Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B
MBH Youdim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
分享论文
